• Without Endings There Are No Beginnings…
• Now is the time for strength.
• No Exon Left Behind
• New Duchenne Therapies in Development
• PPMD Awards $100,000 in Exploratory Grants
• Getting There Faster
• Who Owns Your Clinical Trial Data?

• GSK and Prosensa announce primary endpoint not met in Phase III study of drisapersen
• Positive Phase 1 trial results for SMT C1100 in Duchenne (Summit PLC)
• Now is the time for strength.
• Without Endings There Are No Beginnings…
• Parent Project Muscular Dystrophy awards $50,000 to Dr. Toshifumi Yokota for multi-exon skipping project
• Drug Development Prospects for Duchenne: The Pipeline is rich and deep, with lots of forward momentum
• World Muscle Society Congress: Next Generation Exon-Skipping & Clinical Trial Updates

2015

• January (1)

2014

• December (1)
• July (1)
• April (1)
• March (1)

2013

• November (1)
• October (2)
• September (2)
• April (1)
• February (1)
• January (1)

2012

• November (1)
• October (2)
• September (1)
• August (3)

2011

• November (1)
• April (1)

2010

• November (1)
• September (1)
• July (1)
• May (1)
• April (1)
• February (1)